135 related articles for article (PubMed ID: 11114262)
1. Neurotoxicity of the putative transmembrane domain of the prion protein.
Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
[TBL] [Abstract][Full Text] [Related]
2. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
[TBL] [Abstract][Full Text] [Related]
3. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
4. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo neurotoxicity of prion protein oligomers.
Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
[TBL] [Abstract][Full Text] [Related]
7. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
[TBL] [Abstract][Full Text] [Related]
8. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
9. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
[TBL] [Abstract][Full Text] [Related]
10. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
Brown DR
Mol Cell Neurosci; 2000 Jan; 15(1):66-78. PubMed ID: 10662506
[TBL] [Abstract][Full Text] [Related]
11. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
[TBL] [Abstract][Full Text] [Related]
12. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
[TBL] [Abstract][Full Text] [Related]
13. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxic prion protein (PrP) fragment 106-126 requires the N-terminal half of the hydrophobic region of PrP in the PrP-deficient neuronal cell line.
Sakudo A; Nakamura I; Lee DC; Saeki K; Ikuta K; Onodera T
Protein Pept Lett; 2007; 14(1):1-6. PubMed ID: 17266643
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of prion peptides on cultured cerebellar neurons.
Ciccotosto GD; Cappai R; White AR
Methods Mol Biol; 2008; 459():83-96. PubMed ID: 18576149
[TBL] [Abstract][Full Text] [Related]
17. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
18. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
19. Amyloid toxicity is independent of polypeptide sequence, length and chirality.
Pastor MT; Kümmerer N; Schubert V; Esteras-Chopo A; Dotti CG; López de la Paz M; Serrano L
J Mol Biol; 2008 Jan; 375(3):695-707. PubMed ID: 18036611
[TBL] [Abstract][Full Text] [Related]
20. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
